CAMTA1

calmodulin binding transcription activator 1, the group of Calmodulin binding transcription activators |IPT domain containing

Basic information

Region (hg38): 1:6785454-7769706

Links

ENSG00000171735NCBI:23261OMIM:611501HGNC:18806Uniprot:Q9Y6Y1AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • cerebellar dysfunction with variable cognitive and behavioral abnormalities (Definitive), mode of inheritance: AD
  • cerebellar dysfunction with variable cognitive and behavioral abnormalities (Definitive), mode of inheritance: AD
  • cerebellar dysfunction with variable cognitive and behavioral abnormalities (Supportive), mode of inheritance: AD
  • cerebellar dysfunction with variable cognitive and behavioral abnormalities (Strong), mode of inheritance: AD
  • cerebellar dysfunction with variable cognitive and behavioral abnormalities (Definitive), mode of inheritance: AD

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Cerebellar ataxia, nonprogressive, with mental retardationADGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingNeurologic22693284

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CAMTA1 gene.

  • not_provided (559 variants)
  • Inborn_genetic_diseases (160 variants)
  • Cerebellar_dysfunction_with_variable_cognitive_and_behavioral_abnormalities (142 variants)
  • CAMTA1-related_disorder (51 variants)
  • not_specified (20 variants)
  • Intellectual_disability (10 variants)
  • See_cases (4 variants)
  • Neurodevelopmental_abnormality (3 variants)
  • Neurodevelopmental_disorder (2 variants)
  • Neurodevelopmental_disorder_with_coarse_facies_and_mild_distal_skeletal_abnormalities (2 variants)
  • Developmental_disorder (2 variants)
  • Epilepsy (1 variants)
  • Hereditary_ataxia (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAMTA1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015215.4. Only rare variants are included in the table.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
4
clinvar
133
clinvar
19
clinvar
157
missense
4
clinvar
10
clinvar
392
clinvar
67
clinvar
5
clinvar
478
nonsense
12
clinvar
18
clinvar
1
clinvar
31
start loss
1
1
frameshift
28
clinvar
11
clinvar
2
clinvar
41
splice donor/acceptor (+/-2bp)
1
clinvar
12
clinvar
2
clinvar
15
Total 45 52 402 200 24

Highest pathogenic variant AF is 0.000008227157

Loading clinvar variants...

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CAMTA1protein_codingprotein_codingENST00000303635 23984383
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.006.58e-81257310171257480.0000676
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.267251.02e+30.7120.000065211017
Missense in Polyphen302480.250.628845301
Synonymous0.7114174360.9570.00003263288
Loss of Function7.37776.60.09130.00000413835

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001830.000181
Ashkenazi Jewish0.000.00
East Asian0.0001100.000109
Finnish0.0002480.000231
European (Non-Finnish)0.00004640.0000439
Middle Eastern0.0001100.000109
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Transcriptional activator. May act as a tumor suppressor. {ECO:0000269|PubMed:11925432, ECO:0000269|PubMed:15709179}.;
Disease
DISEASE: Cerebellar ataxia, non-progressive, with mental retardation (CANPMR) [MIM:614756]: A neurodevelopmental disorder characterized by mildly delayed psychomotor development, early onset of cerebellar ataxia, and intellectual disability later in childhood and adult life. Other features may include neonatal hypotonia, dysarthria, and dysmetria. Brain imaging in some patients shows cerebellar atrophy. Dysmorphic facial features are variable. {ECO:0000269|PubMed:22693284}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
miR-targeted genes in muscle cell - TarBase (Consensus)

Intolerance Scores

loftool
0.00455
rvis_EVS
-2.13
rvis_percentile_EVS
1.5

Haploinsufficiency Scores

pHI
0.236
hipred
Y
hipred_score
0.693
ghis
0.609

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.705

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Camta1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype;

Gene ontology

Biological process
positive regulation of protein dephosphorylation;positive regulation of transcription by RNA polymerase II;neuromuscular process controlling balance;positive regulation of calcineurin-NFAT signaling cascade
Cellular component
nucleus;nucleolus;cytosol
Molecular function
DNA-binding transcription factor activity, RNA polymerase II-specific;sequence-specific DNA binding